Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 20Non-Muscle Invasive Bladder Neoplasms 3Hematuria 3Pain 2Carcinoma in Situ 2Urinary Bladder Neck Obstruction 1Urinary Bladder Diseases 1Urinary Bladder Calculi 1Ureteral Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Nephrolithiasis 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lower Urinary Tract Symptoms 1Kidney Diseases 1Carcinoma, Transitional Cell 1Anxiety Disorders 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Cystoscopy × Clear all
NCT05796375 2026-05-04

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡